What does this research mean for the field?

PIK3CA mutations are associated with adverse prognostic outcomes in Sri Lankan breast cancer patients. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to explore the association of PIK3CA mutations with prognostic outcomes in breast cancer patients.

March 10, 2026Open Access

Pattern of Somatic Mutations in the PIK3CA Oncogene and Their Role as a Potential Prognostic Biomarker in Breast Cancer Patients in Sri Lanka: A Pilot Study

Key Points

This research aims to explore the association of PIK3CA mutations with prognostic outcomes in breast cancer patients.
Analyzed somatic mutations in the PIK3CA oncogene.
Examined prognosis in breast cancer patients from Sri Lanka.
Assessed the potential for PIK3CA testing and targeted therapy.
Identified a correlation between PIK3CA mutations and adverse prognostic outcomes.
Indicated the potential for clinical application of PIK3CA testing in treatment strategies.

Abstract

Despite being a pilot study, the findings indicate that PIK3CA mutations are associated with adverse prognostic outcomes in Sri Lankan breast cancer patients. These results demonstrate the potential utility of PIK3CA testing and PI3K-targeted therapy in clinical management in Sri Lankan, pending validation in larger cohorts.

Pattern of Somatic Mutations in the PIK3CA Oncogene and Their Role as a Potential Prognostic Biomarker in Breast Cancer Patients in Sri Lanka: A Pilot Study

Key Points

Abstract

Cite This Study